OCUGEN, INC. Treasury Stock, Value
OCUGEN, INC. (OCGN) had Treasury Stock, Value of $48.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2023-08-21
- 2023-06-30: Treasury Stock, Value $48.00K.
- 2023-03-31: Treasury Stock, Value $48.00K.
- 2022-12-31: Treasury Stock, Value $48.00K.
- 2022-09-30: Treasury Stock, Value $48.00K.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2023-06-30 | $48.00K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $48.00K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $48.00K 10-Q · filed 2023-08-21 | |
| 2022-09-30 | $48.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $48.00K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $48.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $48.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $48.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $48.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $48.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $48.00K 10-K · filed 2022-02-28 | $47.86K 10-K · filed 2021-03-19 |
| 2020-09-30 | $47.86K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $47.86K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $47.86K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $47.86K 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |